FOSL2 and systemic sclerosis: MiR-5196 exogenous delivery reduced the expression of transcription factor Fra2 (Fos-related antigen-2) and TIMP-1 (tissue inhibitor of metalloproteinases), hinting that it could be useful as a potential regulator of SSc fibrogenesis.